Golden House Ltd (TLV:GOHO)
Israel · Delayed Price · Currency is ILS · Price in ILA 1,240.00
-18.00 (-1.43%)
Sep 4, 2025, 5:24 PM IDT
Golden House Revenue
Golden House had revenue of 11.11M ILS in the quarter ending June 30, 2025, with 22.19% growth. This brings the company's revenue in the last twelve months to 43.29M, down -5.33% year-over-year. In the year 2024, Golden House had annual revenue of 39.82M, down -26.66%.
Revenue (ttm)
43.29M
Revenue Growth
-5.33%
P/S Ratio
4.50
Revenue / Employee
373.22K
Employees
116
Market Cap
194.73M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 39.82M | -14.48M | -26.66% |
| Dec 31, 2023 | 54.30M | -1.68M | -3.00% |
| Dec 31, 2022 | 55.97M | -237.00K | -0.42% |
| Dec 31, 2021 | 56.21M | -3.80M | -6.33% |
| Dec 31, 2020 | 60.01M | 3.40M | 6.01% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Teva Pharmaceutical Industries | 56.02B |
| Danel (Adir Yeoshua) | 2.84B |
| Kamada | 571.15M |
| Bait Bakfar | 106.25M |
| BrainsWay | 155.27M |
| SofWave Medical | 234.12M |
| Novolog (Pharm-Up 1966) | 2.04B |
| Ilex Medical | 922.54M |